Brief: Arocell: New Publication On TK 210 ELISA In Prostate Cancer
20/03/2019 11:50
March 20 (Reuters) - AroCell AB (publ) AROC.ST :
* NEW SCIENTIFIC PUBLICATION FROM AROCELL ON TK 210 ELISA IN
PROSTATE CANCER
* COMBINATION OF TK1 WITH PSAD OR TK1 WITH PHI HAS
SIGNIFICANTLY
HIGHER SENSITIVITY THAN THOSE FOR INDIVIDUAL PSA-RELATED
BIOMARKERS
* RESULTS SUGGEST THAT TK1 PROTEIN DETERMINATIONS WITH PHI
OR PSAD
COULD BE VALUABLE TOOL IN PROSTATE CANCER MANAGEMENT
Source text for Eikon: ID:nGNE7mWGKn
Further company coverage: AROC.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))